Reducing venous access failures. Improving lives. Saving millions.

Dialysis is the primary lifeline for patients with end-stage renal disease (ESRD). Unfortunately, 40 - 60% of dialysis grafts fail within the first year, reducing the quality and length of life for patients.

Financial repercussions are also enormous. The extra costs to the Centers for Medicare and Medicaid Services (CMS) created by these failures amounts to approximately $1 Billion per year.  

VenoStent strives to address these issues with its development of SelfWrap - an external stent designed to reduce failures at the vein-graft or vein-artery junction of dialysis patients. SelfWrap attempts to reduce collapse of the vein at this critical interface by promoting outward vein growth and providing durable, flexible, custom-fit mechanical support.